Planta Med 2008; 74(3): 258-263
DOI: 10.1055/s-2008-1034315
Pharmacology
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Separation and SAR Study of HIF-1α Inhibitory Tubulosines from Alangium cf. longiflorum

Paul Klausmeyer1 , Thomas G. McCloud1 , Badarch Uranchimeg2 , Giovanni Melillo2 , Dominic A. Scudiero3 , John H. Cardellina4  II , Robert H. Shoemaker4
  • 1Natural Products Support Group, NCI-Frederick, Frederick, Maryland, USA
  • 2DTP Tumor Hypoxia Laboratory, NCI-Frederick, Frederick, Maryland, USA
  • 3Molecular Target Screening Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA
  • 4Screening Technologies Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI-Frederick, Frederick, Maryland, USA
Further Information

Publication History

Received: October 18, 2007 Revised: January 15, 2008

Accepted: January 16, 2008

Publication Date:
26 February 2008 (online)

Preview

Abstract

A crude organic solvent extract of Alangium cf. longiflorum exhibited potent inhibition of hypoxia-induced HIF-1 transcriptional activity in human U251 glioma cells. Dereplication and bioactivity-guided fractionation, including Sephadex LH-20 and chiral HPLC chromatographies, led to the isolation of tubulosine (1), 9-desmethyltubulosine (2), and isotubulosine (3). Structures were verified by complete 1H and 13C assignments using 1D- and 2D-NMR techniques. Tubulosine strongly inhibited HIF-1 transcriptional activity, isotubulosine was devoid of activity, and 9-desmethyltubulosine possessed 6-fold less potency than tubulosine.

References

Thomas G. McCloud

Natural Products Support Group

SAIC-Frederick, Inc.

NCI Frederick

Frederick

Maryland 21702-1201

USA

Phone: +1-301-846-5750

Fax: +1-301-846-5206

Email: mccloud@dtpax2.ncifcrf.gov